After a period of about nine months apparently on hold, the clinical trial of the AbioCor replacement heart made by Abiomed (Danvers, Massachusetts) picked up speed last month, with the company reporting a second implant in January, the two most recent at Jewish Hospital in Louisville, Kentucky.